Virologic outcomes with tenofovir-lamivudine-dolutegravir in adults failing PI-based second-line ART

Background: In South African antiretroviral guidelines, selected patients failing second-line protease inhibitor (PI)-based therapy qualify for genotypic resistance testing – those with PI resistance receive darunavir-based third-line regimens; those without PI resistance continue current regimen wi...

Full description

Bibliographic Details

Published in:	Southern African Journal of HIV Medicine
Main Authors:	Ying Zhao, Jacqueline Voget, Isaac Singini, Zaayid Omar, Vanessa Mudaly, Andrew Boulle, Gary Maartens, Graeme Meintjes
Format:	Article
Language:	English
Published:	AOSIS 2024-04-01
Subjects:	antiretroviral therapy dolutegravir hiv virologic failure third-line.
Online Access:	https://sajhivmed.org.za/index.php/hivmed/article/view/1567